InvestorsObserver
Sign Up Login

TWST Twist Bioscience Corp

$36.35 $-1.07 (-2.86%)
Add to Watchlist Compare
Overall

TWST Stock Analysis Overview

What this means: Twist Bioscience Corp (TWST) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives TWST a rank of 16. Our methodology considers analysis of the company's financial situation and how it has traded recently. TWST rank of 16 means that it ranks below 84% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

TWST Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

TWST Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

TWST Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

TWST Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

TWST Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

TWST Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

TWST Stock Analysis Overview

What this means: Twist Bioscience Corp (TWST) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives TWST a rank of 16. Our methodology considers analysis of the company's financial situation and how it has traded recently. TWST rank of 16 means that it ranks below 84% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full TWST report

TWST Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

TWST Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

TWST Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

TWST Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

TWST Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

TWST Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Twist Bioscience Corp (TWST) Analyst Forecast

TWST Price, Volume, Earnings, and Dividend Date

  • Last Price $36.35
  • Previous Close $37.42
  • Change $-1.07
  • Open $36.11
  • Volume 343,306
  • Avg. Volume (100-day) 985,418
  • Market Cap 2,045,197,818
  • Days Range 35.7401 - 37.12
  • 52-week Range 25.88 - 139.99
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 08/03/22
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Avg. Analyst Rec. Premium
  • Beta 2.264
  • PEG Ratio —

Twist Bioscience Corp (TWST) Company Description

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Twist Bioscience Corp (TWST) Stock Chart

View Interactive TWST chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Diagnostics & Research

Company Price
Lantheus Holdings (LNTH) (LNTH) $63.79
Radnet Inc (RDNT) (RDNT) $19.07
Thermo Fisher Scientific Inc (TMO) (TMO) $548.91
Qiagen N.V. (QGEN) (QGEN) $46.09
Meridian Bioscience (VIVO) (VIVO) $25.99
Dario Health Corp (DRIO) (DRIO) $6.56
Ortho Clinical Diagnostics Plc (OCDX) (OCDX) $17.73
Aclaris Therapts (ACRS) (ACRS) $12.10
Perkinelmer (PKI) (PKI) $143.49
Icon Plc (ICLR) (ICLR) $214.71